197 related articles for article (PubMed ID: 29487204)
1. Metabolic reprogramming in type 2 diabetes and the development of breast cancer.
Martin SD; McGee SL
J Endocrinol; 2018 May; 237(2):R35-R46. PubMed ID: 29487204
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.
Crujeiras AB; Díaz-Lagares A; Carreira MC; Amil M; Casanueva FF
Free Radic Res; 2013 Apr; 47(4):243-56. PubMed ID: 23409968
[TBL] [Abstract][Full Text] [Related]
3. Activation of hypoxia-inducible factor-1α by prolonged in vivo hyperinsulinemia treatment potentiates cancerous progression in estrogen receptor-positive breast cancer cells.
Wang L; Fan J; Yan CY; Ling R; Yun J
Biochem Biophys Res Commun; 2017 Sep; 491(2):545-551. PubMed ID: 28351619
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinemia and type 2 diabetes: impact on cancer.
Novosyadlyy R; LeRoith D
Cell Cycle; 2010 Apr; 9(8):1449-50. PubMed ID: 20372078
[No Abstract] [Full Text] [Related]
6. The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism.
Sankofi BM; Valencia-Rincón E; Sekhri M; Ponton-Almodovar AL; Bernard JJ; Wellberg EA
Front Endocrinol (Lausanne); 2023; 14():1217875. PubMed ID: 37800138
[TBL] [Abstract][Full Text] [Related]
7. Diabetes, Obesity, and Breast Cancer.
Kang C; LeRoith D; Gallagher EJ
Endocrinology; 2018 Nov; 159(11):3801-3812. PubMed ID: 30215698
[TBL] [Abstract][Full Text] [Related]
8. Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer.
Chu PY; Hou MF; Lai JC; Chen LF; Lin CS
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013830
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted Breast Cancer: The Molecular Connection With Obesity.
Feola A; Ricci S; Kouidhi S; Rizzo A; Penon A; Formisano P; Giordano A; Di Carlo A; Di Domenico M
J Cell Physiol; 2017 Jan; 232(1):69-77. PubMed ID: 27363538
[TBL] [Abstract][Full Text] [Related]
10. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
Zimmet P; Boyko EJ; Collier GR; de Courten M
Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
[TBL] [Abstract][Full Text] [Related]
11. The crosstalk within the breast tumor microenvironment in type II diabetes: Implications for cancer disparities.
Ennis CS; Llevenes P; Qiu Y; Dries R; Denis GV
Front Endocrinol (Lausanne); 2022; 13():1044670. PubMed ID: 36531496
[TBL] [Abstract][Full Text] [Related]
12. The molecular mechanisms between metabolic syndrome and breast cancer.
Chen Y; Wen YY; Li ZR; Luo DL; Zhang XH
Biochem Biophys Res Commun; 2016 Mar; 471(4):391-5. PubMed ID: 26891869
[TBL] [Abstract][Full Text] [Related]
13. Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer.
Shum HCE; Wu K; Vadgama J; Wu Y
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675817
[TBL] [Abstract][Full Text] [Related]
14. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
Luchsinger JA
Eur J Pharmacol; 2008 May; 585(1):119-29. PubMed ID: 18384771
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Link between Diabetic Metabolic Dysregulation and Breast Cancer Progression.
Ahmed SBM; Radwan N; Amer S; Saheb Sharif-Askari N; Mahdami A; Samara KA; Halwani R; Jelinek HF
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511575
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: role of hormones, growth factors and specific receptors.
Guastamacchia E; Resta F; Triggiani V; Liso A; Licchelli B; Ghiyasaldin S; Sabbà C; Tafaro E
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Mar; 4(1):59-66. PubMed ID: 15032627
[TBL] [Abstract][Full Text] [Related]
18. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
Vona-Davis L; Howard-McNatt M; Rose DP
Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
[TBL] [Abstract][Full Text] [Related]
19. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.
Quoc Lam B; Shrivastava SK; Shrivastava A; Shankar S; Srivastava RK
J Cell Mol Med; 2020 Jul; 24(14):7706-7716. PubMed ID: 32458441
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and cancer: placing the association in perspective.
Andersen DK
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):81-6. PubMed ID: 23422245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
